Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay

A Ishida, H Shichi, H Fukuoka, N Inoshita, W Ogawa… - Pituitary - Springer
Purpose Refractory prolactinomas resistant to dopamine agonists (DAs) pose a clinical
challenge. Temozolomide (TMZ) is a recommended treatment option, but its effects are …
被引用次数：11 相关文章
[PDF] kobe-u.ac.jp

[PDF][PDF] Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay

A Ishida, H Shichi, H Fukuoka, N Inoshita, W Ogawa… - Pituitary - da.lib.kobe-u.ac.jp
Methods Surgically resected tumor tissues from two patients with refractory prolactinoma
were 33 cultured as 3D spheroids. The effects of TMZ were assessed based on its …

Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay

A Ishida, H Shichi, H Fukuoka, N Inoshita… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose Refractory prolactinomas resistant to dopamine agonists (DAs) pose a clinical
challenge. Temozolomide (TMZ) is a recommended treatment option, but its effects are …

Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay.

A Ishida, H Shichi, H Fukuoka, N Inoshita, W Ogawa… - Pituitary, 2021 - europepmc.org
Purpose Refractory prolactinomas resistant to dopamine agonists (DAs) pose a clinical
challenge. Temozolomide (TMZ) is a recommended treatment option, but its effects are …

[引用][C] Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay

A Ishida, H Shichi, N Inoshita, S Yamada - Pituitary, 2022 - cir.nii.ac.jp
Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas
as assessed using an ex vivo 3D spheroid assay | CiNii Research CiNii 国立情報学研究所 …

[引用][C] Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay

A Ishida, H Shichi, H Fukuoka, N Inoshita, W Ogawa… - Pituitary, 2021 - cir.nii.ac.jp
Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas
as assessed using an ex vivo 3D spheroid assay | CiNii Research CiNii 国立情報学研究所 学術 …